True North Therapeutics, Inc.
8Patents
8Active
8Granted
47Portfolio score
Filing activity: Nov 1, 2013 → Nov 4, 2015
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8945562B2 | Anti-complement C1s antibodies | Physics | 15 | Active |
| US8877197B2 | Anti-complement C1s | Physics | 15 | Active |
| US9074004B2 | Methods of inhibiting activation of complement component C4 with anti-C1s antibodies | Physics | 12 | Active |
| US9074003B2 | Methods of inhibiting activation of complement component C4 with anti-C1s antibodies | Physics | 12 | Active |
| US9206259B2 | Methods of inhibiting complement C4 activation with anti-complement C1S antibodies | Physics | 11 | Active |
| US9512233B2 | Anti-complement C1s antibodies and methods of inhibiting complement C1s activity | Chemistry; Metallurgy | 10 | Active |
| US9562106B2 | Anti-complement C1s antibodies and methods of inhibiting complement C1s activity | Chemistry; Metallurgy | 8 | Active |
| US9562092B2 | Methods of inhibiting complement C4 activation with anti-complement C1s antibodies | Physics | 8 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.